Elsevier introduces Embase AI, a GenAI-powered version of Embase, the leading biomedical literature database. Embase AI ...

Built in partnership with the research community to help users more easily discover, analyze, and synthesize research using trusted data powered by responsible AI ...

Elsevier has introduced Embase AI, a GenAI-powered version of Embase, the biomedical literature database. Embase AI transforms literature searches and other tasks carried out by multiple teams, ...

Embase AI transforms access to biomedical research with natural language search and summarization of millions of biomedical literature records, clinical trials and conference proceedingsKey benefits ...

Embase Enhances Adverse Event Monitoring With Seamless Access Across Biomedical Literature and Regulatory Data With Embase and PharmaPendium, researchers can monitor pre-clinical, ...

TNF-α inhibitors may reduce mortality and inflammation in moderate-to-severe COVID-19 cases. However, further studies are ...

London, 6 May 2025 – Elsevier, a global leader in information and analytics, is announcing the addition of half a million records from ClinicalTrials.gov to its leading biomedical literature database, ...

Embase AI has been built in partnership with the research community to help users more easily discover, analyze and synthesize research using trusted data powered by responsible AI; ...

Elsevier is introducing Embase AI, a GenAI-powered version of Embase, the leading biomedical literature database, to transform literature searches and other tasks carried out by multiple teams, ...

Embase AI transforms access to biomedical research by introducing natural language search and summarization of millions of biomedical literature records, clinical trials and conference proceedingsKey ...